C Diff patient recruiting for Canadian phase 2 clinical trial

Winnipeg based ImmuniMed Inc, needs your help in recruiting Canadian patients for its C Difficile phase 2 clinical trial (https://clinicaltrials.gov/study/NCT04121169). If you know anyone affected by this disease please have them contact us. Company: ImmuniMed Inc. (immunimed.com) Recruiting: Canadian patients for phase 2 clinical Trial.
Disease: Clostridium Difficile or C Diff infection. Treatment: Novel and very safe non-antibiotic treatment taken orally with milk or milk substitute for 10 to 14 days.